These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2275224)

  • 1. Effects of pentoxifylline on proteinuria in normotensive patients with diabetes mellitus.
    White JR; Karam JH; Koda-Kimble MA
    DICP; 1990 Nov; 24(11):1043-5. PubMed ID: 2275224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
    Guerrero-Romero F; Rodríguez-Morán M; Paniagua-Sierra JR; García-Bulnes G; Salas-Ramírez M; Amato D
    Clin Nephrol; 1995 Feb; 43(2):116-21. PubMed ID: 7736673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study.
    Solerte SB; Fioravanti M; Bozzetti A; Schifino N; Patti AL; Fedele P; Viola C; Ferrari E
    Acta Diabetol Lat; 1986; 23(2):171-7. PubMed ID: 3751450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J; Banihashemi MA; Ghezlou M; Afshariani R; Salari S; Moini M; Sagheb MM
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A; Janghorbani M; Rezvanian H; Aminian T; Gharavi M; Amini M
    Nephron Clin Pract; 2005; 99(3):c73-7. PubMed ID: 15665549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.
    Ghorbani A; Omidvar B; Beladi-Mousavi SS; Lak E; Vaziri S
    Nefrologia; 2012; 32(6):790-6. PubMed ID: 23169362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of macroalbuminuria with pentoxifylline in diabetic nephropathy. Report of three cases.
    Gorson DM
    Diabetes Care; 1998 Dec; 21(12):2190-1. PubMed ID: 9839116
    [No Abstract]   [Full Text] [Related]  

  • 8. Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy.
    Solerte SB; Fioravanti M; Patti AL; Schifino N; Zanoletti MG; Inglese V; Ferrari E
    Acta Diabetol Lat; 1987; 24(3):229-39. PubMed ID: 3687315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
    Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF; Mora C; Muros M; García J
    J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline in management of proteinuria in diabetic nephropathy.
    Tripathi K; Prakash J; Appaiha D; Srivastava PK
    Nephron; 1993; 64(4):641-2. PubMed ID: 8366994
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial.
    Rodriguez-Morán M; González-González G; Bermúdez-Barba MV; Medina de la Garza CE; Tamez-Pérez HE; Martínez-Martínez FJ; Guerrero-Romero F
    Clin Nephrol; 2006 Jul; 66(1):3-10. PubMed ID: 16878429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    J Nephrol; 2007; 20(4):410-6. PubMed ID: 17879206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline for diabetic kidney disease.
    Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
    Solerte SB; Ferrari E
    Pharmatherapeutica; 1985; 4(6):341-50. PubMed ID: 4080752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephropathy in type 2 diabetes.
    Mora C; Garcia J; Navarro JF
    N Engl J Med; 2000 Feb; 342(6):441; author reply 442. PubMed ID: 10681230
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
    McCormick BB; Sydor A; Akbari A; Fergusson D; Doucette S; Knoll G
    Am J Kidney Dis; 2008 Sep; 52(3):454-63. PubMed ID: 18433957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes with Nephropathy.
    Rabizadeh S; Dehghani Firouzabadi F; Noshad S; Esteghamati S; Afarideh M; Ghajar A; Ganji M; Saadat M; Heidari B; Najafi MT; Nakhjavani M; Esteghamati A
    Am J Med Sci; 2018 May; 355(5):442-448. PubMed ID: 29753374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
    Chen YM; Lin SL; Chiang WC; Wu KD; Tsai TJ
    Kidney Int; 2006 Apr; 69(8):1410-5. PubMed ID: 16541021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.